Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis

Clinical and Molecular Hepatology

Byung-Cheol Song¹  Hyun Joo Song¹  Seung Uk Jeong¹  Sun-Jin Boo¹  Soo-Young Na¹  Heung Up Kim¹  Eun Kwang Choi¹  Hye Young Jwa¹  Yoo-Kyung Cho¹  Byoung-Wook Lee²  Bong Soo Kim³ 

[1] Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea;Department of Internal Medicine, Yeollin Hospital, Jeju, Korea;Department of Radiology, Jeju National University School of Medicine, Jeju, Korea;

关键词: Hepatitis B virus;    Entecavir;    Esophageal varices;    Liver cirrhosis;   

DOI  :  10.3350/cmh.2016.22.1.183

来源: DOAJ

【 摘 要 】

Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices can regress after such therapy. We report a case of complete regression of esophageal varices during entecavir therapy in patients with HBV-related liver cirrhosis, suggesting that complications of liver cirrhosis such as esophageal varices can regress after the long-term suppression of HBV replication.

【 授权许可】

Unknown